Wenjun Wan

596 total citations
17 papers, 507 citations indexed

About

Wenjun Wan is a scholar working on Biomedical Engineering, Molecular Biology and Oncology. According to data from OpenAlex, Wenjun Wan has authored 17 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomedical Engineering, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Wenjun Wan's work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Immunotherapy and Immune Responses (4 papers). Wenjun Wan is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Immunotherapy and Immune Responses (4 papers). Wenjun Wan collaborates with scholars based in China and Singapore. Wenjun Wan's co-authors include Jun Luo, Xijun Liu, Huaiyu Li, Xianyun Peng, Xuenong Zhang, Gui Huang, Dandan Wang, Bengang You, Mengtian Chen and Yu Wang and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Applied Catalysis B: Environmental.

In The Last Decade

Wenjun Wan

16 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjun Wan China 11 225 225 148 107 71 17 507
Kongshuo Ma China 13 79 0.4× 84 0.4× 179 1.2× 268 2.5× 67 0.9× 30 579
Sipeng Guo China 7 117 0.5× 69 0.3× 84 0.6× 52 0.5× 26 0.4× 9 489
Shin‐Yeong Kim South Korea 15 431 1.9× 95 0.4× 83 0.6× 50 0.5× 17 0.2× 24 700
Bit Na Kim South Korea 8 144 0.6× 85 0.4× 168 1.1× 60 0.6× 14 0.2× 13 524
Tzu-Yin Chen Taiwan 5 224 1.0× 188 0.8× 270 1.8× 99 0.9× 10 0.1× 7 585
Liming Wang China 12 270 1.2× 110 0.5× 233 1.6× 34 0.3× 11 0.2× 26 652
Juanji Hong China 10 166 0.7× 92 0.4× 366 2.5× 240 2.2× 97 1.4× 12 889
Rongrong Zhang China 14 260 1.2× 42 0.2× 95 0.6× 80 0.7× 27 0.4× 35 519
Chen Shao China 15 71 0.3× 97 0.4× 253 1.7× 387 3.6× 79 1.1× 23 724

Countries citing papers authored by Wenjun Wan

Since Specialization
Citations

This map shows the geographic impact of Wenjun Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Wan more than expected).

Fields of papers citing papers by Wenjun Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Wan. The network helps show where Wenjun Wan may publish in the future.

Co-authorship network of co-authors of Wenjun Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Wan. A scholar is included among the top collaborators of Wenjun Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Wan. Wenjun Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Manyu, et al.. (2025). Burden of non-COVID-19 lower respiratory infections in China (1990–2021): a global burden of disease study analysis. Respiratory Research. 26(1). 125–125. 3 indexed citations
2.
Zhao, Lei, Jin Chen, Wenjun Wan, et al.. (2025). Cell Surface‐Tethered Nucleic Acid Therapeutics Program Robust and Tumor‐Responsive Enhancement of Adoptive Cell Therapy. Advanced Materials. 37(27). e2419969–e2419969. 3 indexed citations
3.
Zhang, Peng, et al.. (2024). Systemic Multifunctional Nanovaccines for Potent Personalized Immunotherapy of Acute Myeloid Leukemia. Advanced Materials. 36(40). e2407189–e2407189. 16 indexed citations
4.
Li, Manyu, et al.. (2024). Hepatitis E virus infection during pregnancy: Advances in animal models. Research in Veterinary Science. 180. 105429–105429.
5.
Wan, Wenjun, Jin Chen, Lei Zhao, et al.. (2024). Chemokine‐Based Injectable Navigation System for Enhancing CAR‐T Cell Therapy Against Solid Tumors. Advanced Functional Materials. 34(36). 3 indexed citations
6.
Li, Manyu, et al.. (2023). Development and evaluation of a CRISPR-Cas13a system-based diagnostic for hepatitis E virus. Clinical Chemistry and Laboratory Medicine (CCLM). 62(6). 1237–1247. 6 indexed citations
7.
Wang, Yu, Xiaomei Zhao, Gui Huang, et al.. (2022). A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy. Acta Biomaterialia. 153. 481–493. 33 indexed citations
8.
Chen, Xingye, Shan An, Lei Zhao, et al.. (2022). Enhancing adoptive T cell therapy for solid tumor with cell-surface anchored immune checkpoint inhibitor nanogels. Nanomedicine Nanotechnology Biology and Medicine. 45. 102591–102591. 10 indexed citations
9.
Wan, Wenjun, Gui Huang, Yu Wang, et al.. (2021). Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy. Acta Biomaterialia. 136. 473–484. 41 indexed citations
10.
Wang, Yu, et al.. (2021). Lactate Consumption via Cascaded Enzymes Combined VEGF siRNA for Synergistic Anti‐Proliferation and Anti‐Angiogenesis Therapy of Tumors. Advanced Healthcare Materials. 10(19). e2100799–e2100799. 41 indexed citations
11.
Wang, Dandan, Weiliang Chen, Hui Li, et al.. (2020). Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery. International Journal of Pharmaceutics. 585. 119456–119456. 21 indexed citations
12.
Wan, Wenjun, et al.. (2019). Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1. Experimental and Molecular Pathology. 110. 104278–104278. 17 indexed citations
13.
Wan, Wenjun, Chenxi Qu, Liang Zhang, et al.. (2019). Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy. International Journal of Pharmaceutics. 566. 731–744. 51 indexed citations
14.
Wan, Wenjun, Mengtian Chen, Dandan Wang, et al.. (2019). Stimuli‐responsive nanoparticles for the codelivery of chemotherapeutic agents doxorubicin and siPD‐L1 to enhance the antitumor effect. Journal of Biomedical Materials Research Part B Applied Biomaterials. 108(4). 1710–1724. 14 indexed citations
15.
Chen, Ying, Long Li, Xijun Liu, Wenjun Wan, & Jun Luo. (2019). Synthesis of a synergistic catalyst for oxygen reduction and a Zn–air battery by the in situ coupling of hemin-derived Fe3O4/N-doped graphitic carbon. Materials Research Express. 6(6). 65019–65019. 3 indexed citations
16.
Li, Huaiyu, Wenjun Wan, Xijun Liu, et al.. (2018). Poplar‐Catkin‐Derived N, P Co‐doped Carbon Microtubes as Efficient Oxygen Electrocatalysts for Zn‐Air Batteries. ChemElectroChem. 5(7). 1113–1119. 33 indexed citations
17.
Wan, Wenjun, et al.. (2018). 3D carbon framework-supported CoNi nanoparticles as bifunctional oxygen electrocatalyst for rechargeable Zn-air batteries. Applied Catalysis B: Environmental. 240. 193–200. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026